Clinical Trial Update: Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating panitumumab-IRDye800 as an imaging agent to help detect cancer during surgery in patients with lung cancer; currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Panitumumab-IRDye800

Snippet

Sponsor: Stanford University | Conditions: Lung Carcinoma, Metastatic Malignant Neoplasm in the Lung | Phase 1, Phase 2 | Status: RECRUITING